Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 1/20 | 0.52 |
| ▸ | AHR | P35869 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | MMP12 | P39900 | 1/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24686218 | 0.95 | HCRTR1 (0.49) | HCRTR1AHRMEN1MAPTKMT2A | |
| SCHEMBL12037211 | 0.94 | ESR1 (0.50) | HCRTR1AHRMEN1MAPTKMT2A | |
| SCHEMBL12037163 | 0.94 | ESR1 (0.50) | HCRTR1AHRMEN1MAPTKMT2A | |
| SCHEMBL26973051 | 0.93 | HCRTR1 (0.48) | HCRTR1AHRMEN1MAPTKMT2A | |
| SCHEMBL21117278 | 0.93 | HCRTR1 (0.48) | HCRTR1AHRMEN1MAPTKMT2A | |
| SCHEMBL12037210 | 0.92 | ESR1 (0.48) | HCRTR1AHRMEN1MAPTKMT2A | |
| SCHEMBL22903341 | 0.92 | HCRTR1 (0.47) | HCRTR1AHRMEN1MAPTKMT2A | |
| SCHEMBL24686652 | 0.92 | HCRTR1 (0.47) | HCRTR1AHRMEN1MAPTKMT2A | |
| SCHEMBL23384905 | 0.91 | AHR (0.47) | HCRTR1AHRMEN1MAPTKMT2A | |
| SCHEMBL23633531 | 0.91 | AHR (0.47) | HCRTR1AHRMEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090005557-A1 | Electron-Conjugated Organic Silane Compound and Production Method Thereof | SHARP KABUSHIKI KAISHA (JP) | 2009-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090005557-A1 | Electron-Conjugated Organic Silane Compound and Production Method Thereof | MLX, RNF31, RPS4X | HCRTR1 3004/4885AHR 4473/4885MEN1 568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.